Development of a novel therapeutic method for rheumatoid arthritis by targeting growth factor signaling
Development of a novel therapeutic method for rheumatoid arthritis by targeting growth factor signaling
批准号:
22790929
负责人:
SAEGUSA Jun
金额:
$2.58万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2011
中文摘要
成纤维细胞生长因子和胰岛素样生长因子在类风湿关节炎滑膜增生症的发生发展中起重要作用。我们最近证实,FGF1直接与整合素αvβ3结合,而整合素结合缺陷的FGF1突变体(FGF^R50E)不能诱导细胞增殖;IGF1也是如此。在这里,我们研究了生长因子-整合素相互作用如何参与生长因子信号转导。基因芯片分析显示,与野生型FGF1处理的RA滑膜细胞相比,经成纤维细胞生长因子、R50E处理的RA滑膜细胞中EGR-1mRNA的表达显著降低。FGF1或IGF1能迅速诱导RA滑膜细胞中EGR-1mRNA和蛋白的表达,但在FGF1、R50E或IGFR+36E/R37E处理的滑膜细胞中,EGR-1的表达明显减弱。SiRNA下调EGR-1的表达有助于H_2O_2或依托泊苷诱导的滑膜细胞的凋亡。
英文摘要
FGF and IGF are of interest in the initiation and development of RA synovial hyperplasia. We recently demonstrated that FGF1 binds directly to integrin αvβ3, and that an integrin-binding-defective FGF1 mutant (FGF^R50E) cannot induce cell proliferation; this is also true for IGF1. Here we investigated how the growth factor-integrin interaction is involved in growth factor signaling. The cDNA microarray analysis showed markedly reduced EGR-1 mRNA expression in the FGF^R50E-treated RA synoviocytes, compared to wild-type FGF1-treated cells. EGR-1 mRNA and protein were rapidly induced in RA synoviocytes in response to FGF1 or IGF1, but the EGR-1 expression was significantly impaired in FGF^R50E-or IGFR^36E/R37E-treated synoviocytes. The down-regulation of EGR-1 by siRNA facilitated the apoptosis of synoviocytes treated with H2O2 or etoposide.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1186/ar3339
发表时间:
2011-05-18
期刊:
Arthritis research & therapy
影响因子:
4.9
作者:
[Misaki K, Morinobu A, Saegusa J, Kasagi S, Fujita M, Miyamoto Y, Matsuki F, Kumagai S]
通讯作者:
Kumagai S
Regulatory and pro-inflammatory properties of CD4+ T-cell subsets defined by CD45RA, CCR7, CD27, and CD28 in patients with rheumatoid arthritis.
类风湿性关节炎患者中由 CD45RA、CCR7、CD27 和 CD28 定义的 CD4 T 细胞亚群的调节和促炎特性。
DOI:
--
发表时间:
2012
期刊:
影响因子:
--
作者:
[Matsuki F, Saegusa J, Miyamoto Y, Misaki K, Kumagai S, Morinobu A]
通讯作者:
Morinobu A
アダリムマブ投与RA患者での抗アダリムマブ抗体と治療効果の関係(多施設共同研究)
抗阿达木单抗抗体与接受阿达木单抗治疗的 RA 患者疗效之间的关系(多中心合作研究)
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[Misaki K, Morinobu A, Saegusa J, Kasagi S, Fujita M, Miyamoto Y, Matsuki F, Kumagai S. Trichostatin A, 三枝 淳, 三枝 淳, 三崎 健太, 辻 剛]
通讯作者:
辻 剛
SLE膠原病難治病態に対するAbsorption Profile に基づくシクロスポリン(CsA)の積極的投与
基于吸收曲线主动施用环孢素(CsA)治疗 SLE 胶原病顽固性病理
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[Misaki K, Morinobu A, Saegusa J, Kasagi S, Fujita M, Miyamoto Y, Matsuki F, Kumagai S. Trichostatin A, 三枝 淳, 三枝 淳, 三崎 健太, 辻 剛, 大籔 智奈美, 林 宏樹]
通讯作者:
林 宏樹
強皮症 膠原病患者における血小板マイクロパーティクル
硬皮病胶原病患者的血小板微粒
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[Misaki K, Morinobu A, Saegusa J, Kasagi S, Fujita M, Miyamoto Y, Matsuki F, Kumagai S. Trichostatin A, 三枝 淳, 三枝 淳, 三崎 健太, 辻 剛, 大籔 智奈美]
通讯作者:
大籔 智奈美
共 43 条
Analysis of signaling pathways induced by the binding of IL-1・to integrins
-
批准号:20890126
-
项目类别:Grant-in-Aid for Young Scientists (Start-up)
-
资助金额:$2.11万
-
财政年份:2008
-
负责人:SAEGUSA Jun
-
依托单位:
海外基金